Related references
Note: Only part of the references are listed.Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
P. G. Foulds et al.
NEUROBIOLOGY OF DISEASE (2012)
A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease
Clive Hamlin et al.
NEUROLOGY (2012)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Cellular prion protein electron microscopy: attempts/limits and clues to a synaptic trait. Implications in neurodegeneration process
Jean-Guy Fournier
CELL AND TISSUE RESEARCH (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Mechanistic aspects of Parkinson's disease:: α-synuclein and the biomembrane
Klaus Beyer
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease
Katsuya Satoh et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus
M Jeffrey et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Share Paper
